BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 28162931)

  • 21. Comparison of a home-based (multi) systemic intervention to promoting Medication AdheRence and Self-management among kidney transplant recipients with care-as-usual: the MARS randomized controlled trial protocol.
    Beck DK; Tielen M; Rechards M; Timman R; Boonstra C; Versteegh J; van de Wetering J; Zietse R; van Gelder T; Weimar W; van Saase J; van Busschbach J; Massey EK
    BMC Nephrol; 2020 Aug; 21(1):374. PubMed ID: 32859157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods.
    Liu J; Liu S; Yan J; Yi Q; Huang H
    Clin Ther; 2015 Nov; 37(11):2572-80. PubMed ID: 26519232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.
    Cassuto E; Pageaux GP; Cantarovich D; Rostaing L; Loupy A; Roche B; Duvoux C; Moreau K; Thervet E; Mazouz H; Bourhis Y; Dharancy S; Kessler M;
    Transplantation; 2016 Oct; 100(10):2099-2106. PubMed ID: 27653227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
    Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
    Fischer L; Saliba F; Kaiser GM; De Carlis L; Metselaar HJ; De Simone P; Duvoux C; Nevens F; Fung JJ; Dong G; Rauer B; Junge G;
    Transplantation; 2015 Jul; 99(7):1455-62. PubMed ID: 26151607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated Reminders and Physician Notification to Promote Immunosuppression Adherence Among Kidney Transplant Recipients: A Randomized Trial.
    Reese PP; Bloom RD; Trofe-Clark J; Mussell A; Leidy D; Levsky S; Zhu J; Yang L; Wang W; Troxel A; Feldman HI; Volpp K
    Am J Kidney Dis; 2017 Mar; 69(3):400-409. PubMed ID: 27940063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prophylactic use of sirolimus on bronchiolitis obliterans syndrome development in lung transplant recipients.
    Sacher VY; Fertel D; Srivastava K; Panos A; Nguyen D; Baxter T; Shafazand S; Pham SM
    Ann Thorac Surg; 2014 Jan; 97(1):268-74. PubMed ID: 24119986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes in pediatric solid-organ transplantation.
    LaRosa C; Baluarte HJ; Meyers KE
    Pediatr Transplant; 2011 Mar; 15(2):128-41. PubMed ID: 21309962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
    Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The spectrum of nonadherence with medication in heart, liver, and lung transplant patients assessed in various ways.
    De Bleser L; Dobbels F; Berben L; Vanhaecke J; Verleden G; Nevens F; De Geest S
    Transpl Int; 2011 Sep; 24(9):882-91. PubMed ID: 21740471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial.
    Baran DA; Zucker MJ; Arroyo LH; Camacho M; Goldschmidt ME; Nicholls SJ; Prevost-Fernandez J; Carr C; Adams L; Pardi S; Hou V; Binetti M; McCahill J; Chichetti J; Viloria V; Sanagustin MG; Ebuenga-Smith J; Mele L; Martin A; Blicharz D; Wolski K; Olesnicky L; Qian F; Gass AL; Cohen M
    Circ Heart Fail; 2011 Mar; 4(2):129-37. PubMed ID: 21216835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroid-Sparing and Optimization of Mycophenolic Acid Exposure in Liver Transplant Recipients Receiving Mycophenolate Mofetil and Tacrolimus: A Randomized, Multicenter Study.
    Saliba F; Rostaing L; Gugenheim J; Durand F; Radenne S; Leroy V; Neau-Cransac M; Calmus Y; Salamé E; Pageaux GP; Duvoux C; Taguieva N; Sinnasse-Raymond G; Sebagh M; Samuel D; Marquet P
    Transplantation; 2016 Aug; 100(8):1705-13. PubMed ID: 27454919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-reported non-adherence to immunosuppressive medication in adult lung transplant recipients-A single-center cross-sectional study.
    Drick N; Seeliger B; Fuge J; Tudorache I; Greer M; Welte T; Haverich A; Gottlieb J
    Clin Transplant; 2018 Apr; 32(4):e13214. PubMed ID: 29380445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients.
    Park JM; Lake KD; Arenas JD; Fontana RJ
    Liver Transpl; 2006 Jan; 12(1):112-6. PubMed ID: 16382458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
    Orme ME; Jurewicz WA; Kumar N; McKechnie TL
    Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes.
    Geng L; Wang LD; Huang JJ; Shen T; Wang ZY; Lin BY; Ye YF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):204-209. PubMed ID: 29807766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative introduction and maintenance immunosuppression therapy of oral-only tacrolimus, mycophenolate mofetil and steroids reduce acute rejection episodes after lung transplantation.
    Bittner HB; Barten MJ; Binner C; Lehmann S; Garbade J; Hammerschmidt S; Wirtz H; Mohr FW
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):268-76. PubMed ID: 20304665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do empowered stroke patients perform better at self-management and functional recovery after a stroke? A randomized controlled trial.
    Sit JW; Chair SY; Choi KC; Chan CW; Lee DT; Chan AW; Cheung JL; Tang SW; Chan PS; Taylor-Piliae RE
    Clin Interv Aging; 2016; 11():1441-1450. PubMed ID: 27789938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to immunosuppression in adult lung transplant recipients: prevalence and risk factors.
    Bosma OH; Vermeulen KM; Verschuuren EA; Erasmus ME; van der Bij W
    J Heart Lung Transplant; 2011 Nov; 30(11):1275-80. PubMed ID: 21724418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.